June 12, 2025

Understanding the TGA’s Reforms on Point-of-Care Medical Device Manufacturing

The landscape of medical device manufacturing is evolving rapidly, with technological advancements enabling healthcare facilities to produce devices on-site, tailored to individual patient needs. Recognising this shift, the Therapeutic Goods Administration (TGA) is undertaking a comprehensive review of regulations pertaining to point-of-care (POC) manufacturing in Australia.

What is Point-of-Care Manufacturing?

POC manufacturing refers to the creation of medical devices within healthcare settings like hospitals, clinics, and dental practices, often utilising technologies such as 3D printing. This approach allows for the rapid production of patient-specific devices, enhancing treatment outcomes and operational efficiency.

TGA’s Regulatory Review: Objectives and Actions

The TGA’s review aims to ensure that POC manufacturing practices maintain high safety and quality standards without imposing unnecessary burdens on healthcare providers. Key actions include:

  • Formation of a Steering Committee and Sector-Specific Working Groups: These bodies are tasked with evaluating current POC manufacturing practices and recommending appropriate regulatory frameworks.
  • Stakeholder Engagement: Surveys and consultations have been conducted across various sectors, including allied health, dental, and hospital manufacturing hubs, to gather comprehensive insights.
  • Focus on Personalised Medical Devices: The review pays particular attention to devices customised for individual patients, assessing how existing regulations apply to these innovations.

Implications for Healthcare Providers and Manufacturers

Entities involved in POC manufacturing should anticipate potential changes in regulatory requirements, including:

  • Compliance Obligations: Ensuring that on-site manufacturing processes meet updated safety and quality standards.
  • Documentation and Reporting: Maintaining thorough records of manufacturing practices and device performance.
  • Training and Education: Staying informed about regulatory changes and ensuring staff are adequately trained.

How KD&A Can Assist

Navigating regulatory changes can be complex. Our team offers expertise in:

  • Regulatory Compliance Audits: Assessing current practices against evolving standards.
  • Technical File Development: Supporting the preparation of documentation to demonstrate conformity for POC-manufactured devices.
  • QMS Implementation and Optimisation: Ensuring your quality management system meets the requirements for manufacturing medical devices at the point of care.

The TGA’s proactive approach to regulating POC manufacturing reflects the dynamic nature of healthcare innovation. By staying informed and prepared, healthcare providers and manufacturers can continue to deliver high-quality, personalised care within a compliant framework. For assistance contact us at kdent@kdas.com.au or at the contact page of our site https://kdas.com.au/contact/. 

For more information on this topic from the TGA refer to this page, https://www.tga.gov.au/how-we-regulate/supply-therapeutic-good/supply-medical-device/medical-devices-reforms/point-care-manufacturing-medical-devices